Industry

Global BPH Treatment Device MedCore Market Report 2022: Size, Share & COVID-19 Impact Analysis – Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore” report has been added to ResearchAndMarkets.com’s offering. The total global BPH treatment device market is growing at a rate of 5.2%, which will take the 2021 market value of $1.2 billion up to $1.7 billion by 2028. … [Read more…]

Insights on the Enzyme Replacement Therapy Global Market to 2028 – Players Include Sanofi, BioMarin Pharmaceutical and Takeda Pharmaceutical – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Enzyme Replacement Therapy Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User” report has been added to ResearchAndMarkets.com’s offering. The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028; it … [Read more…]

United States Assisted Living Facility Market Trends/Analysis Report 2022-2030 with Qualitative Analysis of COVID-19 Impacts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Assisted Living Facility Market Size, Share & Trends Analysis Report by Age (More Than 85, 75-84, 65-74, Less Than 65), Region (West, South, Midwest), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. assisted living facility market size is expected to reach USD 140.8 billion by 2030 and … [Read more…]

United States Pruritus Market and Competitive Landscape Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales 2019-2021 & 2022-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Pruritus Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Pruritus pipeline products, Pruritus epidemiology, Pruritus market valuations and forecast, Pruritus drugs sales and competitive landscape in the US. The research is classified into seven sections – Pruritus treatment options, pipeline products, … [Read more…]

VitalConnect Announces Investment from HCA Healthcare to Accelerate Commercial Growth and Create Strategic Partnership

Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one … [Read more…]

Aicardi Goutieres Syndrome Epidemiology Forecasts Report 2019-2032: Focus on 7MM – United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Aicardi Goutieres Syndrome – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Aicardi-Goutieres Syndrome (AGS) – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Aicardi-Goutieres Syndrome (AGS) in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

Ventricular Tachycardia (V-tach or VT) Drug Pipeline Insight Report 2022 Featuring Espero BioPharma, CTP amio Vivasc Therapeutics, Aladorian – ARMGO Pharma, & RyR2 Research Program – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022″ report provides comprehensive insights about 5+ companies and 7+ pipeline drugs in Ventricular Tachycardia (V-tach or VT) pipeline landscape. It covers the pipeline drug profiles, including … [Read more…]

Generalized Myasthenia Gravis (gMG) Epidemiology Forecasts Report 2019-2032: Focus on 7MM – United States, Germany, Spain, Italy, France, United Kingdom, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Generalized Myasthenia Gravis (gMG) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Generalized Myasthenia Gravis (gMG)- Epidemiology Forecast – 2032’ report delivers an in-depth understanding of Generalized Myasthenia Gravis (gMG) historical and forecasted epidemiology in the United States, EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

– The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body and neurodevelopmental conditions, showed a mean percentage improvement of 37% in the second efficacy trial based on the scoring system of SKATBT-A3. – The first efficacy trial using personalized TCM … [Read more…]

New Research from the Clarify Health Institute Highlights the Severity of Pediatric Mental Health Conditions in the United States

SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, today announced the publication of new research on pediatric mental health in a brief titled, “The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016 – 2021.” The research was conducted by the Clarify Health Institute, which is led by … [Read more…]